Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT03391466 · COMPLETED
Trial details
- NCT number
- NCT03391466
- Sponsor
- Kite, A Gilead Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-25
- Primary completion
- 2021-03-18
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.